eMedevents

GENERAL THORACIC SURGERY: Predictors of Survival After Treatment of Oligometastases After Esophagectomy is organized by The Society of Thoracic Surgeons (STS) and will be held during Feb 01, 2018 - Feb 01, 2020.

The target audience for this medical event is consists of thoracic and cardiothoracic surgeons, pediatric cardiac surgeons, general surgeons, anesthesiologists, oncologists, cardiologists, pulmonologists, and radiologists. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credit.

Course Description :
Each STS CME activity in The Annals consists of a self-study test on an original article from one of the journal's major subject categories (Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Cardiothoracic Anesthesiology), a statement of the learning objectives and an evaluation of the activity.

Course Objectives:
• state the number of deaths from esophageal cancer each year in the United States.
• discuss the percentage of patients who will develop recurrence after curative-attempt esophagectomy for esophageal cancer.
• predict when the vast majority of the recurrences develop after curative-attempt esophagectomy.
• explain that even though surgery was used in these patients with oligometastatic esophageal cancer, it was not the sole therapy in the majority of cases.
• outline the median survival time after surgical resection of oligometastatic esophageal cancer.

Additional details will be posted as soon as they are available.

Intended Audience

Thoracic Surgery

Activity Payment Details

Activity Fee : USD $509.00

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

The Society of Thoracic Surgeons (STS)

View Organizer Details

Help

312-202-5800